Jan C. Drooger

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol et al. · European Journal of Cancer · 2020 · 77 citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +10

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

Anna van der Voort, Fleur M. Louis, Mette S. van Ramshorst et al. · The Lancet Oncology · 2024 · 36 citations · Full text

Neoadjuvant Chemotherapy Duration, Breast Oncology, Medical Imaging +10

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age

Jan C. Drooger, Delal Akdeniz, Jean‐Philippe Pignol et al. · Breast Cancer Research and Treatment · 2015 · 33 citations · Full text

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

Nathalie I. Bouwer, Tessa G. Steenbruggen, Joost van Rosmalen et al. · Breast Cancer Research and Treatment · 2021 · 25 citations · Full text

Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies

Nathalie van den Tempel, Hanny Odijk, Netteke van Holthe et al. · International Journal of Hyperthermia · 2017 · 24 citations · Full text